Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.07 HKD | +1.29% | -2.65% | +4.49% |
15/04 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
15/04 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |